MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind Max Drawdown (5Y) : 69.35% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 69.35% |
| June 30, 2026 | 69.35% |
| May 31, 2026 | 69.35% |
| April 30, 2026 | 69.35% |
| March 31, 2026 | 69.35% |
| February 28, 2026 | 68.70% |
| January 31, 2026 | 68.70% |
| December 31, 2025 | 70.93% |
| November 30, 2025 | 74.63% |
| October 31, 2025 | 86.06% |
| September 30, 2025 | 90.53% |
| August 31, 2025 | 91.94% |
| July 31, 2025 | 92.62% |
| June 30, 2025 | 94.45% |
| May 31, 2025 | 96.18% |
| April 30, 2025 | 96.71% |
| March 31, 2025 | 97.40% |
| February 28, 2025 | 97.67% |
| January 31, 2025 | 97.67% |
| December 31, 2024 | 97.67% |
| November 30, 2024 | 97.67% |
| October 31, 2024 | 97.67% |
| September 30, 2024 | 97.67% |
| August 31, 2024 | 97.67% |
| July 31, 2024 | 97.67% |
| Date | Value |
|---|---|
| June 30, 2024 | 97.87% |
| May 31, 2024 | 98.01% |
| April 30, 2024 | 98.01% |
| March 31, 2024 | 98.01% |
| February 29, 2024 | 98.01% |
| January 31, 2024 | 98.01% |
| December 31, 2023 | 98.07% |
| November 30, 2023 | 98.14% |
| October 31, 2023 | 98.14% |
| September 30, 2023 | 98.14% |
| August 31, 2023 | 98.14% |
| July 31, 2023 | 98.16% |
| June 30, 2023 | 98.16% |
| May 31, 2023 | 98.16% |
| April 30, 2023 | 98.16% |
| March 31, 2023 | 98.16% |
| February 28, 2023 | 98.16% |
| January 31, 2023 | 98.16% |
| December 31, 2022 | 98.16% |
| November 30, 2022 | 98.16% |
| October 31, 2022 | 98.16% |
| September 30, 2022 | 98.16% |
| August 31, 2022 | 98.16% |
| July 31, 2022 | 98.16% |
| June 30, 2022 | 98.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| United Therapeutics Corp. | 33.00% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Gilead Sciences, Inc. | 26.58% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Ocugen, Inc. | 99.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -14.95 |
| Beta (5Y) | 1.124 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 56.98% |
| Historical Sharpe Ratio (5Y) | -0.0807 |
| Historical Sortino (5Y) | -0.1373 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.57% |